Kingsview Wealth Management LLC Boosts Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Kingsview Wealth Management LLC boosted its position in HCA Healthcare, Inc. (NYSE:HCA) by 396.1% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 7,387 shares of the company’s stock after acquiring an additional 5,898 shares during the period. Kingsview Wealth Management LLC’s holdings in HCA Healthcare were worth $3,002,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. CreativeOne Wealth LLC bought a new stake in shares of HCA Healthcare in the first quarter worth about $231,000. Advisors Asset Management Inc. raised its stake in shares of HCA Healthcare by 117.5% in the first quarter. Advisors Asset Management Inc. now owns 2,543 shares of the company’s stock worth $848,000 after purchasing an additional 1,374 shares during the last quarter. LRI Investments LLC bought a new stake in HCA Healthcare in the 1st quarter worth approximately $69,000. BOKF NA boosted its stake in shares of HCA Healthcare by 3.3% during the 1st quarter. BOKF NA now owns 4,541 shares of the company’s stock worth $1,499,000 after acquiring an additional 144 shares during the last quarter. Finally, SVB Wealth LLC increased its position in HCA Healthcare by 48.1% in the first quarter. SVB Wealth LLC now owns 4,183 shares of the company’s stock worth $1,395,000 after buying an additional 1,358 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Trading Down 2.2 %

Shares of NYSE HCA opened at $324.93 on Monday. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a 52-week low of $245.84 and a 52-week high of $417.14. The stock’s 50 day moving average price is $379.40 and its two-hundred day moving average price is $358.70. The stock has a market capitalization of $82.30 billion, a P/E ratio of 14.59, a PEG ratio of 1.28 and a beta of 1.68.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be paid a dividend of $0.66 per share. The ex-dividend date is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.81%. HCA Healthcare’s dividend payout ratio is presently 11.85%.

Analyst Upgrades and Downgrades

Several research firms have recently commented on HCA. Truist Financial boosted their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. TD Cowen decreased their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research note on Monday, October 28th. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Wells Fargo & Company boosted their price objective on shares of HCA Healthcare from $395.00 to $400.00 and gave the stock an “equal weight” rating in a research note on Wednesday, November 6th. Finally, Raymond James cut HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday. Six research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $385.00.

Insider Transactions at HCA Healthcare

In other news, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. This represents a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,155 shares of company stock valued at $5,608,990 in the last quarter. Insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.